Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin
Crossref DOI link: https://doi.org/10.1007/s00345-015-1636-y
Published Online: 2015-07-17
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van de Putte, Elisabeth E. Fransen
Mertens, Laura S.
Meijer, Richard P.
van der Heijden, Michiel S.
Bex, Axel
van der Poel, Henk G.
Kerst, J. Martijn
Bergman, Andries M.
Horenblas, Simon
van Rhijn, Bas W. G.
Text and Data Mining valid from 2015-07-17